Immunogen (IMGN) Tops Q4 EPS by 4c, FY Revenue Guidance Misses
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Nasdaq rallies as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts IMGN Hot Sheet
Price: $31.25 --0%
Financial Fact:
Other (expense) income, net: 129K
Today's EPS Names:
INM, TRI, CRVL, More
Financial Fact:
Other (expense) income, net: 129K
Today's EPS Names:
INM, TRI, CRVL, More
Join SI Premium – FREE
Immunogen (NASDAQ: IMGN) reported Q4 EPS of ($0.28), $0.04 better than the analyst estimate of ($0.32). Revenue for the quarter came in at $13.8 million versus the consensus estimate of $12.27 million.
GUIDANCE:
Immunogen sees FY2019 revenue of $40-45 million, versus the consensus of $84.56 million.
For earnings history and earnings-related data on Immunogen (IMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sotera Health Co. (SHC) Tops Q3 EPS by 2c; Offers Guidance
- IPG Photonics (IPGP) Tops Q3 EPS by 15c ; Offers Guidance
- Canadian crude discount with U.S. at widest level since 2018
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
